title: iTRAQ based quantitative proteomics approach validated the role of calcyclin binding protein (CacyBP) in promoting colorectal cancer metastasis.
abstract: Keeping continuity with our previous study that revealed direct correlations between CRC metastasis and enhanced CacyBP protein levels, here we attempt to improve our understanding of the mechanisms involved within this enigmatic process. Overexpression of CacyBP (CacyBP-OE) in primary CRC cell and its knock down (CacyBP-KD) in the metastatic CRC cells revealed (through phenotypic studies) the positive impact of the protein on metastasis. Additionally, two individual 4-plex iTRAQ based comparative proteomics experiments were carried out on the CacyBP-OE and CacyBP-KD cells, each with two biological replicates. Mining of proteomics data identified total 279 (63.80% up-regulated and 36.20% down-regulated) proteins to be significantly altered in expression level for the OE set and in the KD set, this number was 328 (48.78% up-regulated and 51.22% down-regulated). Functional implications of these significantly regulated proteins were related to metastatic phenotypes such as cell migration, invasion, adhesion and proliferation. Gene ontology analysis identified integrin signaling as the topmost network regulated within CacyBP-OE. Further detection of caveolar mediated endocytosis in the top hit list correlated this phenomenon with the dissociation of integrins from the focal adhesion complex which are known to provide the traction force for cell movement when transported back to the leading edge. This finding was further supported by the data obtained from CacyBP-KD data set showing down-regulation of proteins necessary for integrin endocytosis. Furthermore, intracellular calcium levels (known to influence integrin mediated cell migration) were found to be lowered in CacyBP-KD cells indicating decreased cell motility and vice versa for the CacyBP-OE cells. Actin nucleation by ARP-WASP complex, known to promote cell migration, was also identified as one of the top regulated pathways in CacyBP-OE cells. In short, this study presents CacyBP as a promising candidate biomarker for CRC metastasis and also sheds light on the underlying molecular mechanism by which CacyBP promotes CRC metastasis.
authors.affiliation: Department of Biological Sciences, National University of Singapore, Singapore.
authors.forename: Dipanjana
authors.initials: D
authors.lastname: Ghosh
authors.forename: Zhihan
authors.initials: Z
authors.lastname: Li
authors.forename: Xing Fei
authors.initials: XF
authors.lastname: Tan
authors.forename: Teck Kwang
authors.initials: TK
authors.lastname: Lim
authors.forename: Yubin
authors.initials: Y
authors.lastname: Mao
authors.forename: Qingsong
authors.initials: Q
authors.lastname: Lin
mesh_terms: D002135:Calcium-Binding Proteins / Q000378:metabolism*; D002448:Cell Adhesion; D002465:Cell Movement; D015179:Colorectal Neoplasms / Q000378:metabolism* / Q000473:pathology; D045325:HCT116 Cells; D006801:Humans; D009362:Neoplasm Metastasis; D009363:Neoplasm Proteins / Q000378:metabolism; D040901:Proteomics / Q000379:methods
chemical_list: C491778:CACYBP protein, human; D002135:Calcium-Binding Proteins; D009363:Neoplasm Proteins
references.citation: Blood. 2003 Nov 15;102(10):3629-36
references.pmid: 12881299
references.citation: Zhonghua Zhong Liu Za Zhi. 2002 Sep;24(5):426-9
references.pmid: 12485490
references.citation: Mol Biol Cell. 2010 Sep 1;21(17):2996-3006
references.pmid: 20631255
references.citation: Curr Opin Cell Biol. 2011 Oct;23(5):607-14
references.pmid: 21924601
references.citation: Biochem Biophys Res Commun. 2007 May 18;356(4):864-71
references.pmid: 17400182
references.citation: J Cell Biol. 2005 Jan 31;168(3):441-52
references.pmid: 15684033
references.citation: World J Surg. 2010 Nov;34(11):2545-52
references.pmid: 20585948
references.citation: Cancer Sci. 2010 Mar;101(3):658-65
references.pmid: 20047593
references.citation: Am J Pathol. 2011 Nov;179(5):2559-68
references.pmid: 21907176
references.citation: Nat Rev Cancer. 2009 Apr;9(4):265-73
references.pmid: 19262571
references.citation: J Biol Chem. 2010 Oct 1;285(40):30480-8
references.pmid: 20670935
references.citation: Cell. 2008 May 16;133(4):704-15
references.pmid: 18485877
references.citation: Nat Rev Mol Cell Biol. 2005 Jan;6(1):56-68
references.pmid: 15688067
references.citation: J Proteomics. 2012 Jun 6;75(10):3031-40
references.pmid: 22178447
references.citation: Mol Vis. 2009 Oct 23;15:2162-73
references.pmid: 19898636
references.citation: Biochim Biophys Acta. 2009 Dec;1796(2):293-308
references.pmid: 19683560
references.citation: Biochem Biophys Res Commun. 2008 Oct 10;375(1):134-8
references.pmid: 18680720
references.citation: Cell Calcium. 2005 May;37(5):395-402
references.pmid: 15820386
references.citation: J Biol Chem. 2012 Mar 23;287(13):9835-9844
references.pmid: 22308039
references.citation: J Biol Chem. 2000 Oct 6;275(40):31178-82
references.pmid: 10884380
references.citation: Invest Ophthalmol Vis Sci. 2006 Jan;47(1):415-26
references.pmid: 16384992
references.citation: Mol Cell. 2001 May;7(5):915-26
references.pmid: 11389839
references.citation: Blood. 2012 Jan 19;119(3):838-46
references.pmid: 22128142
references.citation: Protoplasma. 2002 Feb;219(1-2):1-12
references.pmid: 11926060
references.citation: Int J Cell Biol. 2012;2012:310616
references.pmid: 22319531
references.citation: Mol Cell Biochem. 2012 Jan;359(1-2):323-32
references.pmid: 21861103
references.citation: Biochim Biophys Acta. 2012 Jul;1820(7):1111-20
references.pmid: 22366469
references.citation: Biochim Biophys Acta. 2000 Dec 20;1498(2-3):91-8
references.pmid: 11108953
references.citation: Cancer Commun. 1990;2(10):345-55
references.pmid: 2206777
references.citation: Biochim Biophys Acta. 2012 Jun;1818(6):1526-35
references.pmid: 22100746
references.citation: Zhonghua Yi Xue Za Zhi. 2006 Dec 12;86(46):3264-8
references.pmid: 17313807
references.citation: Steroids. 2011 Sep-Oct;76(10-11):1063-8
references.pmid: 21570421
references.citation: J Proteome Res. 2010 Oct 1;9(10):5108-17
references.pmid: 20707403
references.citation: Int J Oncol. 2006 Mar;28(3):715-22
references.pmid: 16465377
references.citation: Proc Natl Acad Sci U S A. 2011 Feb 1;108(5):1897-902
references.pmid: 21224412
references.citation: Mol Carcinog. 2011 Aug;50(8):601-13
references.pmid: 21374739
references.citation: Cancer Res. 2006 May 1;66(9):4734-41
references.pmid: 16651426
references.citation: Cancer Res. 2009 Oct 1;69(19):7548-56
references.pmid: 19773446
references.citation: J Neurochem. 1998 May;70(5):1793-8
references.pmid: 9572262
references.citation: J Proteome Res. 2007 Feb;6(2):821-7
references.pmid: 17269738
references.citation: Oncol Rep. 2012 Apr;27(4):917-22
references.pmid: 22200787
references.citation: Am J Pathol. 2010 Mar;176(3):1157-68
references.pmid: 20093499
references.citation: J Biol Chem. 2006 Mar 10;281(10):6776-84
references.pmid: 16407243
references.citation: Med Mol Morphol. 2009 Mar;42(1):9-15
references.pmid: 19294487
references.citation: J Biol Chem. 2011 Nov 25;286(47):40922-33
references.pmid: 21969374
references.citation: Biochim Biophys Acta. 2009 Nov;1792(11):1052-61
references.pmid: 19679182
references.citation: Mol Cancer Res. 2007 Dec;5(12):1254-62
references.pmid: 18171983
references.citation: J Proteome Res. 2011 Oct 7;10(10):4373-87
references.pmid: 21854069
references.citation: J Cell Sci. 2003 Dec 15;116(Pt 24):4915-24
references.pmid: 14625385
references.citation: Biochem J. 2011 Feb 15;434(1):171-80
references.pmid: 21126233
references.citation: J Cell Sci. 2010 Nov 15;123(Pt 22):3901-12
references.pmid: 20980389
references.citation: Cancer Metastasis Rev. 2010 Mar;29(1):223-37
references.pmid: 20112053
references.citation: J Biochem. 2012 Jan;151(1):99-108
references.pmid: 21937675
references.citation: Gastric Cancer. 2004;7(3):160-6
references.pmid: 15449204
references.citation: Gynecol Endocrinol. 2007 Jun;23(6):351-5
references.pmid: 17616861
references.citation: J Histochem Cytochem. 2000 Sep;48(9):1195-202
references.pmid: 10950876